...
首页> 外文期刊>Future medicinal chemistry >Ligand design for riboswitches, an emerging target class for novel antibiotics
【24h】

Ligand design for riboswitches, an emerging target class for novel antibiotics

机译:RiboSwitches的配体设计,新兴抗生素的新兴目标类

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Riboswitches are cis-acting gene regulatory elements and constitute potential targets for new antibiotics. Recent studies in this field have started to explore these targets for drug discovery. New ligands found by fragment screening, design of analogs of the natural ligands or serendipitously by phenotypic screening have shown antibacterial effects in cell assays against a range of bacteria strains and in animal models. In this review, we highlight the most advanced drug design work of riboswitch ligands and discuss the challenges in the field with respect to the development of antibiotics with a new mechanism of action.
机译:Riboswitches是CIS作用基因调节因素,构成新抗生素的潜在目标。 该领域的最近研究已经开始探索这些药物发现的目标。 通过片段筛选发现的新配体,天然配体的类似物或通过表型筛选偶然的设计表现出对细胞测定对一系列细菌菌株和动物模型的抗菌作用。 在这篇综述中,我们突出了Riboswitch配体的最先进的药物设计作品,并讨论了与新的行动机制抗生素发展的挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号